Top Banner
The Inter-rater Reliability and Intra-rater Reliability of Bedside Ultrasounds of the Femoral Muscle Thickness Daren K. Heyland, MD, MSc, FRCPC Professor of Medicine Queen’s University, Kingston General Hospital Kingston, Ontario
12

Daren K. Heyland, MD, MSc, FRCPC Professor of Medicine

Mar 22, 2016

Download

Documents

hallam

The Inter-rater Reliability and Intra-rater Reliability of Bedside Ultrasounds of the Femoral Muscle Thickness. Daren K. Heyland, MD, MSc, FRCPC Professor of Medicine Queen’s University, Kingston General Hospital Kingston, Ontario. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

The Inter-rater Reliability and Intra-rater Reliability of Bedside Ultrasounds of the

Femoral Muscle Thickness

Daren K. Heyland, MD, MSc, FRCPCProfessor of MedicineQueen’s University, Kingston General HospitalKingston, Ontario

Page 2: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

A Randomized Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients:

The TOP UP TrialHypothesis: Increased energy and protein delivery to underweight and overweight critically illpatients (Body Mass Index [BMI] <25 or >35) will result in improved 60 day survival compared to usual care.

• Multicenter pilot study• Randomized trial of 160 critically ill adult patients from 8 tertiary care ICU’s in

Canada, United States, and Europe.• Patients randomized to one of 2 interventions: enteral nutrition (EN) alone or enteral

nutrition plus parenteral nutrition (supplemental PN group). • Patients stratified on the basis of admission BMI: <25 or >35, medical or surgical

admission diagnosis, by site and if EN was administered between ICU admission and randomization

Primary outcome: 60 day mortality.Secondary outcomes: 28 day mortality, hospital mortality, duration of stay (ICU and hospital), multiple organ dysfunction (SOFA and PODS), duration of mechanical ventilation, development of ICU acquired infections, functional status at hospital discharge, and 3 and 6 month survival and health-related quality of life.

Page 3: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Weekly Ultrasounds• There is emerging evidence that muscle mass and muscle function predict

morbidity in surviving patients and that muscle mass at ICU admission may predict length of hospital stay.

• We propose to evaluate the effect of differential amounts of protein and energy provided to study patients on muscle mass and function.

• We can postulate that the beneficial effect of enhanced energy and protein provision is mediated by the preservation (or attenuated deterioration) of muscle mass and increased function in these better fed patients, which would ultimately result in positive outcomes.

• We will evaluate muscle mass in all study patients using non-invasive bedside ultrasound of the femoral muscle

Page 4: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Testing Ultrasound Reliability before TOP-UPBefore we performed weekly ultrasounds on the study population, we conducted a trial of the ultrasound protocol to allow us to:

•standardize the training of all Study Investigators performing the ultrasound assessment•test the feasibility of the procedures •determine ‘normal’ values to which we can compare our measures in the study population•determine intra-rater (trainer) and the inter-rater (trainee) reliability.

The ultrasound reliability trial involved:• the 7 participating TOP UP sites• healthy volunteers• a standardized protocol:

o ultrasound trainers were to perform ultrasounds twice on each patiento a trainee repeated the measurement on the same patient

The objective was to evaluate the inter-rater reliability and intra-rater reliability of bedside ultrasounds of the femoral muscle measuring muscle thickness in healthy volunteers before using this tool in detailing overall muscle mass in ICU patients.

Page 5: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Reliability Protocol1) Trainer to complete a 2/3rd and midpoint ultrasound on each leg2) Trainer to repeat a 2/3rd and midpoint ultrasound on each leg (intra-rater reliability test)3) Trainee to complete a 2/3rd and midpoint ultrasound on each leg (inter-rater reliability test)

The overall muscle thickness was calculated as the average of the readings measured at the border between the lower third and upper two-thirds between Anterior Superior Iliac Spine (ASIS) and upper pole of the patella as well as the reading at the midpoint between the ASIS and the upper pole of the patella averaged over the right and left legs.

Page 6: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Volunteers’ Demographics

Variable N Mean Std Dev Minimum Maximum

Age

Height

Weight

BMI

64

78

78

78

30.6

171.4

71.2

24.1

8.4

11.5

16.4

4.4

21.0

135.0

46.0

16.9

55.0

196.0

136.4

40.7

Page 7: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Intra-rater Reliability ResultsSite Subjects Between Subject Variance Within Subject Variance ICC

Erasme University Hospital, Brussels, Belgium

10 0.2307 0.01380 0.94

Grey Nuns Hospital, Edmonton, Alberta, Canada

0 NA NA NA

Royal Alexandra Hospital, Edmonton, Alberta, Canada

10 0.2425 0.001018 >0.99

Nouvel Hôpital Civil, Strasbourg, France

4 0.2567 0.000199 >0.99

University of Alberta HospitalEdmonton, Alberta, Canada

12 0.05866 0.003180 0.95

University of Colorado, Aurora, Colorado, USA

5 0.2869 0.000613 >0.99

University of Texas Health Science Center, Houston, Texas, USA

5 0.1774 0.003837 0.98

Pooled 46 0.2648 0.004554 0.98

ICC: Intra-class correlation coefficient, ICC = between subject variance / (between subject variance +within subject variance)

Page 8: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Intra-rater Reliability Results (Continued)

The mean difference between trainer measurements (95% CI) = 0.037 (0.010 to 0.063) p=0.0077

Mean difference between trainer measurement 1 and trainer measurement 2

Trainer measurement 1 Trainer measurement 2

• The paired t-test was used examine the average difference between the first and second trainer measurements.

• The paired profile plot visualizes the difference in the paired measures.

Page 9: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Inter-rater Reliability ResultsSite Subjects Between Subject Variance Within Subject Variance ICC

Erasme University Hospital, Brussels, Belgium

10 0.2194 0.02900 0.88

Grey Nuns Hospital, Edmonton, Alberta, Canada

13 0.3217 0.000769 >0.99

Royal Alexandra Hospital, Edmonton, Alberta, Canada

10 0.2305 0.02072 0.92

Nouvel Hôpital Civil, Strasbourg, France

18 0.2623 0.009972 0.96

University of Alberta HospitalEdmonton, Alberta, Canada

12 0.03587 0.01360 0.73

University of Colorado, Aurora, Colorado, USA

5 0.1714 0.02746 0.86

University of Texas Health Science Center, Houston, Texas, USA

5 0.1704 0.03334 0.84

Pooled 73 0.2584 0.01580 0.94

ICC: Intra-class correlation coefficient, ICC = between subject variance / (between subject variance +within subject variance)

Page 10: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Inter-rater Reliability Results (Continued)

There was a small but statistically significant difference between the trainer and trainee results: Mean (95% CI) = -0.061 cm (-0.100 to -0.022), p= 0.0028

Mean difference between trainer measurement and trainee measurement

Trainer Trainee

• The paired t-test was used examine the average difference between the first trainer and the trainee measurement.

• Paired profile plots are provided to visualize the difference in the paired measures.

Page 11: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Conclusion

• There is excellent inter and intra-rater reliability for ultrasound measurements of the femoral muscle to determine overall muscle thickness in healthy volunteers.

• A sample of ‘normal’ values is now available to compare measures from a study population.

• Further evaluation of this technique must be validated in critically ill patients.

• Efforts to link the ultrasound measurements to ICU outcomes should be undertaken.

Page 12: Daren K.  Heyland, MD, MSc, FRCPC Professor of Medicine

Questions